Characterization of the immune response to Leishmania infantum recombinant antigens

Microbes and Infection

Volumn 5, Issue 1, 2003, Pages 7-12

  De Carvalho, Lucas Pedreira ^a   Soto, Manuel ^b   Jerônimo, Selma ^c   Dondji, Blaise ^d   Bacellar, Olívia ^a   Luz, Viviane ^c   Orge, Glória Orge ^a   Alonso, Carlos ^b   Jesus, Amélia R ^a   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^d UNIVERSITY OF NGAOUNDERE   (Cameroon)

Author keywords

IFN ; Immuneregulation; KMP11; Leishmaniasis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; LEISHMANIA INFANTUM ANTIGEN; PARASITE ANTIGEN; PROTOZOON ANTIBODY; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CELL CULTURE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEISHMANIA BRAZILIENSIS; LEISHMANIA CHAGASI; LEISHMANIA INFANTUM; MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIGENS, PROTOZOAN; CELLS, CULTURED; HUMANS; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-5; LEISHMANIA INFANTUM; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MEMBRANE GLYCOPROTEINS; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS;

LEISHMANIA INFANTUM;

EID: 12244263784     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00051-5     Document Type: Article

References (31)

1. Desjeux P. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 14:1996;417-423.
2. Marsden P.D., Sampaio R.N., Carvalho E.M., Veiga J.P., Costa J.L., Llanos-Cuentas E.A. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis. Am. J. Trop. Med. Hyg. 34:1985;710-713.
3. Burns J.M. Jr, Scott J.M., Carvalho E.M., Russo D.M., March C.J., Van Ness K.P., Reed S.G. Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses. J. Immunol. 146:1991;742-748.
4. Skeiky Y.A., Kennedy M., Kaufman D., Borges M.M., Guderian J.A., Scholler J.K., Ovendale P.J., Picha K.S., Morrissey P.J., Grabstein K.H., Campos-Neto A., Reed S.G. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. J. Immunol. 161:1998;6171-6179.
5. Russo D.M., Burns J.M. Jr, Carvalho E.M., Armitage R.J., Grabstein K.H., Button L.L., McMaster W.R., Reed S.G. Human T cell responses to gp63, a surface antigen of Leishmania. J. Immunol. 147:1991;3575-3580.
6. Scott P., Natovitz P., Coffman R.L., Pearce E., Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. M. 168:1988;1675-1684.
7. Murray H.W., Rubin B.Y., Rothermel C.D. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J. Clin. Invest. 72:1983;1506-1510.
8. Carvalho E.M., Johnson W.D., Barreto E., Marsden P.D., Costa J.L., Reed S., Rocha H. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J. Immunol. 135:1985;4144-4148.
9. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceicao-Silva F., Modlin R.L. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91:1993;1390-1395.
10. Castes M., Trujillo D., Rojas M.E., Fernandez C.T., Araya L., Cabrera M., Blackwell J., Convit J. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol. Res. 26:1993;233-238.
11. Ribeiro-de-Jesus A., Almeida R.P., Lessa H., Bacellar O., Carvalho E.M. Cytokine profile and pathology in human leishmaniasis. Braz. J. Med. Biol. Res. 31:1998;143-148.
12. Lessa H.A., Machado P., Lima F., Cruz A.A., Bacellar O., Guerreiro J., Carvalho E.M. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am. J. Trop. Med. Hyg. 65:2001;87-89.
13. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. M. 170:1989;2081-2095.
14. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
15. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. M. 174:1991;1209-1220.
16. Bacellar O., D'Oliveira A. Jr, Jeronimo S., Carvalho E.M. IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine. 12:2000;1228-1231.
17. Cook J.W., Karakozis S., Kim D., Provido H., Gongora E., Kirkpatrick J.R. Interleukin-10 attenuates proinflammatory cytokine production and improves survival in lethal pancreatitis. Am. Surg. 67:2001;237-241. discussion 241-232.
18. Rezende S.A., Silva-Teixeira D.N., Drummond S.C., Goes A.M. IL-10 plays a role in the modulation of human granulomatous hypersensitivity against Schistosoma mansoni eggs induced by immune complexes. Scand. J. Immunol. 46:1997;96-102.
19. Jeronimo S.M., Teixeira M.J., Sousa A., Thielking P., Pearson R.D., Evans T.G. Natural history of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: long-term follow-up. Clin. Infect. Dis. 30:2000;608-609.
20. Soto M., Requena J.M., Gomez L.C., Navarrete I., Alonso C. Molecular characterization of a Leishmania donovani infantum antigen identified as histone H2A. Eur. J. Biochem. 205:1992;211-216.
21. Soto M., Requena J.M., Morales G., Alonso C. The Leishmania infantum histone H3 possesses an extremely divergent N-terminal domain. Biochim. Biophys. Acta. 1219:1994;533-535.
22. Reed S.G., Badaro R., Masur H., Carvalho E.M., Lorenco R., Lisboa A., Teixeira R., Johnson W.D. Jr, Jones T.C. Selection of a skin test antigen for American visceral leishmaniasis. Am. J. Trop. Med. Hyg. 35:1986;79-85.
23. Badaro R., Reed S.G., Barral A., Orge G., Jones T.C. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses. Am. J. Trop. Med. Hyg. 35:1986;72-78.
24. Carvalho E.M., Bacellar O., Barral A., Badaro R., Johnson Jr W.D. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. J. Clin. Invest. 83:1989;860-864.
25. Carvalho E.M., Badaro R., Reed S.G., Jones T.C., Johnson Jr W.D. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 76:1985;2066-2069.
26. Carvalho E.M., Barral A., Pedral-Sampaio D., Barral-Netto M., Badaro R., Rocha H., Johnson Jr W.D. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J. Infect. Dis. 165:1992;535-540.
27. Sacks D.L., Lal S.L., Shrivastava S.N., Blackwell J., Neva F.A. An analysis of T cell responsiveness in Indian kala-azar. J. Immunol. 138:1987;908-913.
28. Bomfim G., Nascimento C., Costa J., Carvalho E.M., Barral-Netto M., Barral A. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis. Exp. Parasitol. 84:1996;188-194.
29. Pauza M.E., Neal H., Hagenbaugh A., Cheroutre H., Lo D. T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes. Diabetes. 48:1999;1948-1953.
30. Yang J.S., Xu L.Y., Huang Y.M., Van Der Meide P.H., Link H., Xiao B.G. Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin-12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis. Immunology. 101:2000;397-403.
31. Thomas M.C., Longobardo M.V., Carmelo E., Maranon C., Planelles L., Patarroyo M.E., Alonso C., Lopez M.C. Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera. Clin. Exp. Immunol. 123:2001;465-471.